Studies related to Fibromyalgia and D-Ribose

The Use Of D-ribose In Chronic Fatigue Syndrome And Fibromyalgia: A Pilot Study

Effect Decrease
Trial Design Non-controlled trial
Trial Length 2-4 Weeks
Number of Subjects 36
Sex Both Genders
Age Range 45-64
Notes for this study:
Supplementation of 15g D-ribose (three doses of 5g) over the course of approximately 18 days in subjects with fibromyalgia and/or chronic fatigue syndrome was able to improve subjective well being (30%) and subjective feelings of energy (45%) while improving mental clarity and increasing the pain threshold.

Improvements relative to baseline, as there was no placebo control used in this study.
Funding issues for this study:
Product provided by Valen Labs, a supplement producer of which one author consults for an another works with